文献速递创伤与烧伤复苏、休克与脓毒症

早期氨甲环酸给药可改善创伤与休克体外模型中的创伤性内皮病

Early tranexamic acid administration ameliorates the endotheliopathy of trauma and shock in an in vitro model.
PubMed 文献 · J Trauma Acute Care Surg · 2017-01-01
一句话结论体外实验显示,在过氧化氢/肾上腺素刺激后60分钟内给予氨甲环酸可消除内皮-糖萼双屏障损伤,超过60分钟则无保护作用。

该研究为体外实验,用人脐静脉内皮细胞暴露于过氧化氢和/或肾上腺素模拟创伤/失血性休克后的氧化应激和交感肾上腺激活,评估氨甲环酸在不同时间点给药对血管内皮活化和损伤的影响。结果显示,过氧化氢/肾上腺素暴露导致内皮通透性增加、ICAM表达上调、可溶性血栓调节蛋白升高,并呈现促纤溶特征(tPA及tPA/PAI-1比值升高)和血管渗漏(APO-2/APO-1比值升高)。在刺激后60分钟内给予氨甲环酸可消除对内皮-糖萼双屏障的不良影响,而60分钟后给药无保护作用。作者结论认为氨甲环酸对内皮损伤的保护效应具有时间依赖性,支持其临床疗效需要早期给药的概念。

要点

  • 体外实验中,过氧化氢/肾上腺素暴露导致内皮通透性、ICAM表达和可溶性血栓调节蛋白增加,并出现促纤溶特征(tPA及tPA/PAI-1比值升高)。
  • 氨甲环酸在过氧化氢/肾上腺素刺激后60分钟内给药,可消除对内皮-糖萼双屏障的不良影响。
  • 氨甲环酸在刺激后超过60分钟给药则无保护作用,提示其保护效应具有时间依赖性。
  • 血管渗漏以APO-2/APO-1比值升高为指标,在过氧化氢/肾上腺素暴露后明显,最显著效应见于过氧化氢/肾上腺素联合暴露。

适用人群与场景

  • 体外实验,使用融合的人脐静脉内皮细胞,模拟创伤/失血性休克后的内皮损伤,非直接来自患者人群。

处置流程与药物剂量

  • 在过氧化氢/肾上腺素刺激后15分钟、60分钟或120分钟加入氨甲环酸;原文未给出氨甲环酸的剂量、浓度或给药途径。

研究设计与关键结果

  • 体外实验显示,过氧化氢和/或肾上腺素暴露增加内皮通透性、ICAM表达和可溶性血栓调节蛋白,并呈现促纤溶特征(tPA及tPA/PAI-1比值升高)和APO-2/APO-1比值升高。
  • 过氧化氢/肾上腺素联合暴露时上述效应最显著。
  • 在刺激后60分钟内给予氨甲环酸可消除对内皮-糖萼双屏障的不良影响;刺激后超过60分钟给药无保护作用。

证据类型、等级与局限

  • 证据类型:体外实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该体外实验支持氨甲环酸对内皮损伤的保护效应具有时间依赖性,与临床早期给药的概念一致;作者认为临床疗效需要早期给药。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Systemic vascular endothelial injury is a consequence of trauma (T)/hemorrhagic shock (HS) which results in disturbances of coagulation, inflammation, and endothelial barrier integrity. The effect of T/HS on the endothelium (endotheliopathy of trauma [EoT]) is of intense research interest and may lead to EoT-directed therapies. Administration of tranexamic acid (TXA) in trauma patients is associated with a survival benefit and fewer complications if given early after injury. Mechanisms for this protective effect include the antifibrinolytic and anti-inflammatory effects of TXA. We hypothesized that "early" administration of TXA would abrogate vascular endothelial cell activation and injury after T/HS. This was studied in vitro.

METHODS: Confluent human umbilical vein endothelial cells were exposed to hydrogen peroxide and/or epinephrine to stimulate post-T/HS oxidant exposure and/or sympathoadrenal activation. TXA was added 15 minutes, 60 minutes, or 120 minutes after H2O2 and/or epinephrine challenge. Endothelial cell injury was indexed by cell monolayer permeability, intracellular adhesion molecule expression, soluble thrombomodulin, syndecan release (marker for glycocalyx injury), tissue type plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1) and angiopoietin-2/angiopoietin-1 ratio (APO-2/APO-1).

RESULTS: Endothelial activation and injury as indexed by permeability, ICAM expression, soluble thrombomodulin were increased by H2O2 and/or epinephrine exposure. Biomarkers of endothelial coagulation profile (tPA/PAI-1) demonstrated a profibrinolytic profile (increased tPA and tPA/PAI-1 ratio) after challenge by H2O2 and/or epinephrine. Vascular "leakiness" as indexed by APO-2/APO-1 ratio was also evident. The most profound effects were noted with H2O2/epinephrine exposure. TXA administration within 60 minutes of H2O2/epinephrine challenge abolished the adverse effects noted on the endothelial-glycocalyx "double barrier." TXA administration after 60 minutes was not protective.

CONCLUSION: Antifibrinolytic and other protective effects of TXA administration on endothelial injury are time-dependent. This study supports the concept that the clinical efficacy of TXA administration requires "early administration."

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Diebel LN, Martin JV, Liberati DM, et al. Early tranexamic acid administration ameliorates the endotheliopathy of trauma and shock in an in vitro model. J Trauma Acute Care Surg. 2017. PMID: 28328682. doi:10.1097/TA.0000000000001445

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。